MedCity News12d
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
MedPage Today13d
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
Managed Healthcare Executive13d
New FTC Report: PBMs Mark Up Specialty Generic Drugs
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The Hill14d
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The commission noted these prices were in excess of the National Average Drug Acquisition Cost (NADAC) for these drugs. As is noted in the report, there is no set definition for what specialty ...
Benefits Pro14d
FTC accuses big PBMs' pharmacies of collecting $5.9B in specialty drug markups
based on National Average Drug Acquisition Cost statistics, officials said. The gap between what the plans paid over that period and the drug acquisition costs was $5.9 billion for commercial ...
NPR14d
Drugmakers hiked prices for hundreds of drugs in early January
An earlier version of this story incorrectly stated that 46brooklyn uses National Average Drug Acquisition Cost, or NADAC, in ...
ctpublic14d
Drugmakers hiked prices for hundreds of drugs in early January
An earlier version of this story incorrectly stated that 46brooklyn uses National Average Drug Acquisition Cost, or NADAC, in its analysis of price hikes. They use Elsevier wholesale acquisition cost ...